Literature DB >> 14594108

Identification of two novel mutations in the human growth hormone receptor gene.

O Shevah1, P Borrelli, M Rubinstein, Z Laron.   

Abstract

Deletions and mutations in the growth hormone receptor gene are the underlying etiology of Laron syndrome (LS). Most of the patients are distributed in and originating from the Mediterranean and Middle-Eastern countries. Thirty-nine mutations have been described so far. We hereby report 2 novel nonsense mutations, one in exon 2 found in three Jewish-Iraqi patients from Israel; and another in exon 6 found in an Italian girl. DNA sequencing of exon 2 revealed a G to A transition at nucleotide 83 in the fourth codon of the signal peptide (W-15X). In exon 6, a T to A transversion was found in amino acid 141 (L141X). Both mutations introduced a premature termination codon that led to a truncated non-functioning receptor. In addition we found in the Jewish-Iraqi patients, a mutation in exon 7 (R211H, previously described) and in the Italian family the polymorphism Gly168, in exon 6.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14594108     DOI: 10.1007/BF03347015

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  16 in total

1.  Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism.

Authors:  P J Godowski; D W Leung; L R Meacham; J P Galgani; R Hellmiss; R Keret; P S Rotwein; J S Parks; Z Laron; W I Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain.

Authors:  K Iida; Y Takahashi; H Kaji; O Nose; Y Okimura; H Abe; K Chihara
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

3.  Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses.

Authors:  Z Laron; A Pertzelan; M Karp; A Kowadlo-Silbergeld; W H Daughaday
Journal:  J Clin Endocrinol Metab       Date:  1971-08       Impact factor: 5.958

4.  Pituitary dwarfism with high serum levels of growth hormone.

Authors:  Z Laron; A Pertzelan; M Karp
Journal:  Isr J Med Sci       Date:  1968 Jul-Aug

5.  A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein.

Authors:  K A Woods; N C Fraser; M C Postel-Vinay; M O Savage; A J Clark
Journal:  J Clin Endocrinol Metab       Date:  1996-05       Impact factor: 5.958

6.  Intronic mutation in the growth hormone (GH) receptor gene from a girl with Laron syndrome and extremely high serum GH binding protein: extended phenotypic study in a very large pedigree.

Authors:  A Silbergeld; F Dastot; B Klinger; H Kanety; R Eshet; S Amselem; Z Laron
Journal:  J Pediatr Endocrinol Metab       Date:  1997 May-Jun       Impact factor: 1.634

7.  New growth hormone receptor exon 9 mutation causes genetic short stature.

Authors:  R M Ayling; R J Ross; P Towner; S Von Laue; J Finidori; S Moutoussamy; C R Buchanan; P E Clayton; M R Norman
Journal:  Acta Paediatr Suppl       Date:  1999-02

8.  Laron syndrome due to a post-receptor defect: response to IGF-I treatment.

Authors:  Z Laron; B Klinger; R Eshet; H Kaneti; A Karasik; A Silbergeld
Journal:  Isr J Med Sci       Date:  1993-12

9.  Characterization of a noncontiguous gene deletion of the growth hormone receptor in Laron's syndrome.

Authors:  L R Meacham; M R Brown; T L Murphy; R Keret; A Silbergeld; Z Laron; J S Parks
Journal:  J Clin Endocrinol Metab       Date:  1993-11       Impact factor: 5.958

10.  Spectrum of growth hormone receptor mutations and associated haplotypes in Laron syndrome.

Authors:  S Amselem; P Duquesnoy; B Duriez; F Dastot; M L Sobrier; S Valleix; M Goossens
Journal:  Hum Mol Genet       Date:  1993-04       Impact factor: 6.150

View more
  1 in total

1.  Growth hormone receptor gene mutations in two Italian patients with Laron Syndrome.

Authors:  L Fassone; G Corneli; S Bellone; C Camacho-Hübner; G Aimaretti; M Cappa; G Ubertini; G Bona
Journal:  J Endocrinol Invest       Date:  2007-05       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.